Favourable safety profile in marked contrast to traditional inotropic therapeuticsAC01 showed rapid and sustained numerical ...

A "polypill" combining three medications recommended to treat heart failure into a single daily dose proved far more ...

A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain people ...

Finerenone reduced the composite of total first and recurrent heart failure (HF) events (hospitalizations for HF or urgent HF visits) and cardiovascular death in patients with HF and mildly reduced or ...

Recent developments of interest in cardiovascular medicine ...

LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been established in ...

Patients hospitalized with a common form of heart failure could avoid later hospital stays—and dramatically lower health care costs—if they receive the full combination of four medications currently ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global ...